Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease

BACKGROUND: We investigated whether a panel of 12 potential novel biomarkers consisting of proteins involved in synapse functioning and immunity would be able to distinguish patients with Alzheimer’s disease (AD) and patients with mild cognitive impairment (MCI) from control subjects. METHODS: We in...

Descripción completa

Detalles Bibliográficos
Autores principales: Duits, Flora H., Brinkmalm, Gunnar, Teunissen, Charlotte E., Brinkmalm, Ann, Scheltens, Philip, Van der Flier, Wiesje M., Zetterberg, Henrik, Blennow, Kaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389073/
https://www.ncbi.nlm.nih.gov/pubmed/29370833
http://dx.doi.org/10.1186/s13195-017-0335-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389073/
https://www.ncbi.nlm.nih.gov/pubmed/29370833
http://dx.doi.org/10.1186/s13195-017-0335-x

Ejemplares similares